{"transactions":[{"id":1932062,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":114853,"kind":"person","name":"Leonard John E.","position":1,"cik":"0001747997","reported_name":"Leonard John E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Development"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-04-03T16:35:42.000Z","date":"2023-03-31","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the March 31, 2023 grant date."}],"balance_after":20000,"derivative":{"exercise_price":0.3995,"expiration_date":"2033-03-30","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001062993-23-008326","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000106299323008326/form4.xml","form_type":"4"}},{"id":2307641,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":114853,"kind":"person","name":"Leonard John E.","position":1,"cik":"0001747997","reported_name":"Leonard John E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Development"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-04-04T16:36:15.000Z","date":"2022-04-01","kind":"grant","acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the April 1, 2022 grant date."}],"balance_after":16000,"derivative":{"exercise_price":1.29,"expiration_date":"2032-04-01","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001062993-22-009450","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000106299322009450/form4.xml","form_type":"4"}},{"id":2760701,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":114853,"kind":"person","name":"Leonard John E.","position":1,"cik":"0001747997","reported_name":"Leonard John E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Development"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-02T16:26:40.000Z","date":"2021-04-02","kind":"grant","acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the April 2, 2021 grant date."}],"balance_after":8000,"derivative":{"exercise_price":2.93,"expiration_date":"2031-04-02","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0000891839-21-000099","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000089183921000099/edgar.xml","form_type":"4"}},{"id":3038852,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":114853,"kind":"person","name":"Leonard John E.","position":1,"cik":"0001747997","reported_name":"Leonard John E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Development"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-09-03T16:16:43.000Z","date":"2020-07-14","kind":"exercise","acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the March 15, 2019 grant date."}],"balance_after":3000,"derivative":{"exercise_price":3.9,"expiration_date":"2029-03-14","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0000891839-20-000255","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000089183920000255/edgar.xml","form_type":"4/A","original_submission_date":"2020-07-27"}},{"id":3038851,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":114853,"kind":"person","name":"Leonard John E.","position":1,"cik":"0001747997","reported_name":"Leonard John E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Development"}}],"security":"Common Stock","published_at":"2020-09-03T16:16:43.000Z","date":"2020-07-14","kind":"exercise","acquired":true,"shares":1000,"price":3.9,"value":3900.0,"ownership":{"direct":true},"balance_after":2258,"source":{"system":"sec-edgar","filing":"0000891839-20-000255","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000089183920000255/edgar.xml","form_type":"4/A","original_submission_date":"2020-07-27"}},{"id":3074740,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":114853,"kind":"person","name":"Leonard John E.","position":1,"cik":"0001747997","reported_name":"Leonard John E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Development"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-07-28T16:19:31.000Z","date":"2020-07-27","kind":"exercise","acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the March 15, 2019 grant date."}],"balance_after":3000,"derivative":{"exercise_price":3.9,"expiration_date":"2029-03-14","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0000891839-20-000214","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000089183920000214/edgar.xml","form_type":"4/A","original_submission_date":"2020-07-27"}},{"id":3074739,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":114853,"kind":"person","name":"Leonard John E.","position":1,"cik":"0001747997","reported_name":"Leonard John E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Development"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-07-28T16:19:31.000Z","date":"2020-07-24","kind":"exercise","acquired":false,"shares":1258,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Exercisable in full as of the date of this report."}],"balance_after":23150,"derivative":{"exercise_price":7.1,"expiration_date":"2025-12-22","underlying":"Common Stock","underlying_shares":1258},"source":{"system":"sec-edgar","filing":"0000891839-20-000214","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000089183920000214/edgar.xml","form_type":"4/A","original_submission_date":"2020-07-27"}},{"id":3074738,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":114853,"kind":"person","name":"Leonard John E.","position":1,"cik":"0001747997","reported_name":"Leonard John E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Development"}}],"security":"Common Stock","published_at":"2020-07-28T16:19:31.000Z","date":"2020-07-27","kind":"exercise","acquired":true,"shares":1000,"price":3.9,"value":3900.0,"ownership":{"direct":true},"balance_after":2258,"source":{"system":"sec-edgar","filing":"0000891839-20-000214","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000089183920000214/edgar.xml","form_type":"4/A","original_submission_date":"2020-07-27"}},{"id":3074737,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":114853,"kind":"person","name":"Leonard John E.","position":1,"cik":"0001747997","reported_name":"Leonard John E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Development"}}],"security":"Common Stock","published_at":"2020-07-28T16:19:31.000Z","date":"2020-07-24","kind":"exercise","acquired":true,"shares":1258,"price":7.1,"value":8931.8,"ownership":{"direct":true},"balance_after":1258,"source":{"system":"sec-edgar","filing":"0000891839-20-000214","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000089183920000214/edgar.xml","form_type":"4/A","original_submission_date":"2020-07-27"}},{"id":3075530,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":114853,"kind":"person","name":"Leonard John E.","position":1,"cik":"0001747997","reported_name":"Leonard John E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Development"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-07-27T16:16:43.000Z","date":"2020-07-27","kind":"exercise","acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the March 15, 2019 grant date."}],"balance_after":3000,"derivative":{"exercise_price":3.9,"expiration_date":"2029-03-14","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0000891839-20-000213","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000089183920000213/edgar.xml","form_type":"4"}},{"id":3075529,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":114853,"kind":"person","name":"Leonard John E.","position":1,"cik":"0001747997","reported_name":"Leonard John E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Development"}}],"security":"Common Stock","published_at":"2020-07-27T16:16:43.000Z","date":"2020-07-27","kind":"exercise","acquired":true,"shares":1000,"price":3.9,"value":3900.0,"ownership":{"direct":true},"balance_after":1000,"source":{"system":"sec-edgar","filing":"0000891839-20-000213","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000089183920000213/edgar.xml","form_type":"4"}},{"id":3245965,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":114853,"kind":"person","name":"Leonard John E.","position":1,"cik":"0001747997","reported_name":"Leonard John E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Development"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-26T16:25:02.000Z","date":"2020-02-25","kind":"grant","acquired":true,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the February 25, 2020 grant date."}],"balance_after":4000,"derivative":{"exercise_price":6.07,"expiration_date":"2030-02-24","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0000891839-20-000053","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000089183920000053/edgar.xml","form_type":"4"}},{"id":3586058,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":114853,"kind":"person","name":"Leonard John E.","position":1,"cik":"0001747997","reported_name":"Leonard John E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Development"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-03-19T16:48:24.000Z","date":"2019-03-15","kind":"grant","acquired":true,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the March 15, 2019 grant date."}],"balance_after":4000,"derivative":{"exercise_price":3.9,"expiration_date":"2029-03-14","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0000891839-19-000048","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000089183919000048/edgar.xml","form_type":"4"}}]}